Back to search
FDAFDA · Food and drugs·Recall number Z-2481-2021

BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375

Published September 22, 2021 · Recall initiated: July 30, 2021

Summary

FDA records medical device Class II recall Z-2481-2021, published September 22, 2021 and initiated July 30, 2021. Recalling firm: Leica Microsystems, Inc.; Status: Terminated; Reported quantity: 237 units; Lot: Product Code PA0375, Lot 69909. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product may not perform as specified in IFU.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Leica Microsystems, Inc.
Distributor
US Nationwide distribution.
Lot
Product Code PA0375, Lot 69909
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375 recalled?

Yes. FDA published recall Z-2481-2021 on September 22, 2021. Reported hazard: Product may not perform as specified in IFU.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail